Jin Gu is the Director of Real-World Evidence for Lung/GI Oncology at Gilead Sciences, specializing in RWE strategy development and execution. With a PhD from the University of New Orleans and prior senior roles at Bristol Myers Squibb, Jin has a deep background in observational research and data science.
Jin is a certified SAS Advanced Programmer, demonstrating specialized technical skills in data analysis and statistical programming.
Jin Gu, PhD
Director, RWE Oncology- Lung/GI at Gilead Sciences
New York City Metropolitan Area, United States
Overview
Topics They Care About
RWE Strategy
Leads the development and execution of Real-World Evidence strategies in their role at Gilead Sciences, building on extensive experience in the field.
Oncology Research
Currently focuses on Lung and GI oncology, applying real-world data to advance understanding and treatment in these specific therapeutic areas.
Observational Data
Has significant experience with observational healthcare databases, including EMR and claims data, from their time at Bristol Myers Squibb's CORDS.
Media Appearances
Jin has no verified media appearances
Work History
9-2023
Director, RWE Oncology- Lung/GI at Gilead Sciences
8-2021 - 9-2023
Director - CORDS at Bristol Myers Squibb
10-2017 - 8-2021
Associate Director - Center of Observational Research & Data Science (CORDS) at Bristol Myers Squibb
1-2015 - 10-2017
Statistical Consultant at KMK Consulting - RWE Analytics
Education
2010 - 2014
Doctor of Philosophy (PhD) from University of New Orleans
2008 - 2010
Master's degree from University of New Orleans
More Information
Social Presence :
Prographics :
Exp : 11
Location : New York City Metropolitan Area, United States
Job Level : Mid-senior
Designation : Director, RWE Oncology- Lung/GI at Gilead Sciences
